BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF ENTRECTINIB IN RAT PLASMA BY LIQUID CHROMATOGRAPHY–TANDEM MASS SPECTROMETRY
Objective: The objective of the study was to develop and validate the bioanalytical liquid chromatography–mass spectrometry (LCMS/MS) method for the estimation of entrectinib in bulk and pharmaceutical drugs in rat plasma.
Methods: Chromatographic separation of entrectinib with D4-entrectinib as internal standard (IS) was achieved using Waters Alliance high-performance liquid chromatography system, quaternary gradient pump of e2695, using Luna, 250×4.6 mm, 5 μm column and the mobile phase containing 0.1% formic acid and acetonitrile (ACN) within the ratio of 70:30% v/v. The flow was 1.0 ml/min; detection was carried out by absorption at 294 nm using a photodiode array detector at ambient temperature.
Results: The peak of entrectinib was eluted at retention times of 5.225 min. The multiple reaction monitoring was 560.6/475.1 (m/z) for entrectinib and 580.6/496.3 (m/z) for IS entrectinib (D4). The linearity range was 1–20 ng/ml with a regression coefficient of 0.999. % relative standard deviation of peak areas of all measurements always <2.0.
Conclusion: The method was successfully validated and it had been found to be within limits for accuracy, precision, and linearity and it is stable under analytical conditions used.
2. Available from: https://www.drugbank.ca/drugs/DB11986.
3. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/ label/2019/212725s000lbl.pdf.
4. Udhayavani S, Sastry VG, Rajan RG, Krishna VR, Tejaswi JK. One step quantification analytical method and characterization of valsartan by LC-MS. Int J App Pharm 2018;10:108-11.
5. Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for industry, Bionalytical Method Validation. United States: Food and Drug Administration. Center for Drug Evaluation and Research; 2001.
6. Jemal M, Xia YQ. LC-MS development strategies for quantitative bioanalysis. Curr Drug Metab 2006;7:491-502.
7. Kole PL, Venkatesh G, Kotecha J, Sheshala R. Recent advances in sample preparation techniques for effective bioanalytical methods. Biomed Chromatogr 2011;25:199-217.
8. LC-MS/MS Hardware Manuals for API3000 and API4000.
9. Hartmann C, Smeyers-Verbeke J, Massart DL, McDowall RD. Validation of bioanalytical chromatographic methods. J Pharm Biomed Anal 1998;17:193-218.
10. Rao GR, Murthy SS, Khadgapathi P. High performance liquid chromatography and its role in pharmaceutical analysis (review). East Pharm 1986;29:53.
11. Devanshu S, Rahul M, Annu G, Kishan S, Anroop N. Quantitative bioanalysis by LC-MS/MS, a review. J Pharm Biomed Sci 2010;7:1-7.
12. Prasad PB, Satyanarayana K, Mohan GK. Simultaneous determination of metformin, linagliptin in jentadueto and metformin, saxagliptin in kombiglyze by LC-MS method. Int J Pharm Pharm Sci 2018;10:110-6.
13. Viswanathan CT, Bansal S, Booth B, DeStefano AJ, Rose MJ, Sailstad J, et al. Quantitative bioanalytical methods validation and implementation, best practices for chromatographic and ligand binding assays. AAPS J 2007;24:1962-73.
14. Shah VP. The history of bioanalytical method validation and regulation, evolution of a guidance document on bioanalytical methods validation. AAPS J 2007;9:E43-7.
15. Willard HH, Merrit LL Jr., Dean JA, Settle FA Jr. Instrumental Methods of Analysis. 6th ed. New Delhi, India: CBS Publishers; ???.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.